Interventional Cardiologists specialize in treating heart conditions through procedures that involve catheters inserted into the blood vessels, allowing them to address blockages or abnormalities without major surgery. These medical professionals are highly skilled in performing techniques like coronary angioplasty and stent placement, which help restore proper blood flow to the heart. Their expertise is crucial in both planned and emergency scenarios, where quick action can prevent severe damage to the heart muscle. By relying on advanced imaging and real-time monitoring, they can accurately diagnose and treat conditions like arterial plaque buildup, congenital defects, and narrowed heart valves.
This field focuses heavily on innovation and precision. Interventional cardiologists often collaborate with other healthcare teams to provide comprehensive cardiac care, especially in cases where medication or lifestyle changes are no longer sufficient. Their ability to perform procedures with minimal incisions significantly reduces recovery time and lowers the risk of complications. This makes them an essential part of treating cardiovascular disease in a modern, less invasive way. In addition to coronary interventions, they are also involved in procedures related to peripheral arteries and structural heart problems, offering patients safer options and improved long-term outcomes. Their work continues to evolve with advancements in tools, techniques, and patient care standards.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India